$46.41

0.32 (0.69%)

7/24/2008 2:06 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AZN

Add Stock to Watchlist

What the Community Thinks

Total Members

288 Outperforms

25 Underperforms

All-Stars

106 Outperforms

11 Underperforms

Wall Street

6 Outperforms

2 Underperforms

Members bullish on AZN are also bullish on:

Members bearish on AZN are also bearish on:

Ticker Tags

United Kingdom (50), Mega Cap (146), Major 2006 Lawsuit (3), Dividend (202), Big Pharma (12), Drug Manufacturers - Major (27), Multinational Company (16), Major 2005 Lawsuit (8)
Suggest a tag

AstraZeneca plc (ADR) At A Glance

Current Price:	$46.41
Last Trade Time:	7/24/2008 2:06 PM
Open:	$46.16
Previous Close:	$46.09
Daily Range:	$46.14 - $46.64
52-Week Range:	$35.03 - $54.50
Volume:	610,709
Market Cap:	$66.96B
P/E Ratio:	12.32
Compare Our Special Broker Offers!

Stock Trends

AZN VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for AZN

Astra seeks approval for diabetes drug
7/23/2008 3:00:00 PM - AP
Infinity shares dip on canceled program
7/15/2008 7:45:00 PM - AP
New pharma ethics rules eliminate gifts and meals
7/11/2008 5:28:00 AM - AP
New pharma ethics rules eliminate gifts and meals
7/10/2008 5:32:00 PM - AP

More Headlines...

Top Bull Pitch

Recs

1 AstraZeneca plc (ADR) (AZN)

Avatar manucastle (73.04) Submitted: 7/02/08 10:20 AM

I have purchased AZN today :-

http://finance.yahoo.com/q?s=azn

EPS = 3.74
PE = 11.2 Industry 16.3
PB = 4.13 Industry 3.8
PS = 2.01 Industry 3.0
P/CF = 11.1 Industry 13.3
P/FCF = 87.0 Industry 17.4
Yield 6.5 Industry 1.5
Gross profit margin = 78.7 Industry 71.5
Operating margin = 27.0 Industry 10.0...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1 AstraZeneca plc (ADR) (AZN)

Avatar KingPortu (43.96) Submitted: 10/29/07 2:34 PM

I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off

Replies: 0 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 50 : 1 2 3 4 5 Next » Jump to page:

Recs 0 (AZN) COOLSTOCK (< 20) Submitted: 7/16/08 3:47 PM : Start Price: $45.18 AZN Score: 0.93 CRESTOR NEXIXUM GOOD BRANDS GOOD STOCK Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AZN) ivstaline (< 20) Submitted: 7/09/08 10:40 AM : Start Price: $48.31 AZN Score: -3.38 CRESTOR Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AZN) SierraBlue (67.48) Submitted: 7/08/08 8:22 PM : Start Price: $48.10 AZN Score: -2.70 Major Drug Manufacturers Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (AZN) manucastle (73.04) Submitted: 7/02/08 10:20 AM : Start Price: $44.51 AZN Score: 6.01 I have purchased AZN today :- http://finance.yahoo.com/q?s=azn EPS = 3.74 PE = 11.2 Industry 16.3 PB = 4.13 Industry 3.8 PS = 2.01 Industry 3.0 P/CF = 11.1 Industry 13.3 P/FCF = 87.0 Industry 17.4 Yield 6.5 Industry 1.5 Gross profit margin = 78.7 Industry 71.5 Operating margin = 27.0 Industry 10.0 Net Profit Margin = 18.3 Industry 15.7 ROA = 11.7 Industry 7.9 ROE = 37.6 Industry 14.5 Insider ownership = 1.0 Greenblatt ROC = 86.59 Greenblatt Earnings Yield = 11.27 Passes 13 of 17 of Mikes metrics MaxPrice = 76.76 Discount 46% Metrics from qtr ending 03/31/2008 Zacks rank 3 http://www.zacks.com/research/report.php?t=azn&type=main Caps rank 4 http://caps.fool.com/Ticker/AZN.aspx All good enough for my money. I only suggest stocks that I own ! (See posts 388/584/665/760/1051/1807/2213/3546/3755/4046/4208/4225/4345/4573/4818/ 5169 on 'Investment Analysis Clubs / Dynamic Value Investing ' board for extra due diligence applied ). MaxPrice is a generic version of Mike Klein's Maxprice and ROC and Earnings yields are generic versions of Greenblatt's metrics. See 'Investment Analysis Clubs / Dynamic Value Investing' board and my CAPS profile for further excellent companies selling at a discount to Maxprice with excellent current metrics. CAPS only shows my selections over 100Mill (unfortunately due to restricted lower market cap applied by MF CAPS). As stated on the 'Investment Analysis Clubs /Dynamic Value Investing' board my aim is to obtain up to 50% returns p.a. as Buffett stated he could obtain (3 times) recently. A very difficult task but you can follow along with my buys and sells on my CAPS page, where I put my money where my mouth is . If I perform well I hope you can benefit. If not , feel free to ignore my comments. CAPS allows each and everyone of us to be clinically judged on our stock picking abilities over the LONG TERM. Please always do your own due diligence before investing. Manucastle :o) Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (AZN) catmon (76.97) Submitted: 6/19/08 3:55 PM : Start Price: $41.82 AZN Score: 17.03 Arimidex use will increase sales with favorable ATAC trial released. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 50 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 8 of 8

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackHSBC	89.44	06/26/08		NS	$43.39	+7.08%	-3.05%	-10.12
	TrackJPMorgan	90.25	04/18/08		NS	$41.63	+11.60%	-8.61%	-20.21
	TrackCitigroup	86.96	04/02/08		NS	$40.46	+14.83%	-7.37%	+22.20
	TrackJimCramer	81.64	04/01/08		3W	$40.60	+14.43%	-7.33%	+21.77
	TrackHAndW	< 20	12/31/07		NS	$41.37	+12.31%	-13.42%	+25.73
	TrackEdwardOwens	99.16	09/30/07		NS	$48.37	-3.95%	-17.03%	+13.09
	TrackBrandes	< 20	09/30/07		NS	$48.37	-3.95%	-17.03%	+13.09
	TrackBearStearns	90.97	01/12/07		NS	$52.65	-11.76%	-10.93%	-0.83

Results 1 - 8 of 8

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.